Macroscopic role of microparticles in cardiovascular disease

Area of Science:

• Cardiovascular Research
• Biomarker Discovery
• Hematology

Background:

• Microparticles, also known as extracellular vesicles (EVs), are emerging biomarkers for platelet activation and inflammation.
• Various EV subtypes originate from platelets, endothelial cells, and leukocytes.
• Elevated EV concentrations in patients with acute myocardial infarction, stroke, and peripheral artery disease correlate with disease severity.

Purpose of the Study:

• To explore the role of EVs as diagnostic and prognostic markers for cardiovascular diseases (CVD).
• To evaluate the potential of EV measurement in risk stratification and therapy monitoring for high-risk patients.
• To assess the utility of EVs in monitoring responses to antiplatelet therapies.

Main Methods:

• Standardized methods for EV isolation and detection have been developed.
• Correlation analysis between EV subtypes and disease severity in CVD patients.
• Evaluation of EV concentration changes in response to antiplatelet therapy.

Main Results:

• Blood EV concentrations correlate with disease severity in acute myocardial infarction, stroke, and peripheral artery disease.
• EVs are implicated in the pathogenesis of atherosclerosis and its complications.
• Standardization of EV measurement facilitates further research and clinical application.

Conclusions:

• EV measurement holds promise for minimally-invasive early diagnosis, risk stratification, and monitoring of CVD.
• EV-based tests may guide therapy selection and monitor treatment response, including antiplatelet agents.
• Standardized EV detection paves the way for clinical implementation in routine practice and trials.